203 related articles for article (PubMed ID: 32553184)
41. Roles of Axin in the Wnt signalling pathway.
Kikuchi A
Cell Signal; 1999 Nov; 11(11):777-88. PubMed ID: 10617280
[TBL] [Abstract][Full Text] [Related]
42. USP7 inhibits Wnt/β-catenin signaling through promoting stabilization of Axin.
Ji L; Lu B; Zamponi R; Charlat O; Aversa R; Yang Z; Sigoillot F; Zhu X; Hu T; Reece-Hoyes JS; Russ C; Michaud G; Tchorz JS; Jiang X; Cong F
Nat Commun; 2019 Sep; 10(1):4184. PubMed ID: 31519875
[TBL] [Abstract][Full Text] [Related]
43. Mechanism of phosphorylation-dependent binding of APC to beta-catenin and its role in beta-catenin degradation.
Ha NC; Tonozuka T; Stamos JL; Choi HJ; Weis WI
Mol Cell; 2004 Aug; 15(4):511-21. PubMed ID: 15327768
[TBL] [Abstract][Full Text] [Related]
44. New insights into the regulation of Axin function in canonical Wnt signaling pathway.
Song X; Wang S; Li L
Protein Cell; 2014 Mar; 5(3):186-93. PubMed ID: 24474204
[TBL] [Abstract][Full Text] [Related]
45. Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of beta-catenin.
Kishida S; Yamamoto H; Ikeda S; Kishida M; Sakamoto I; Koyama S; Kikuchi A
J Biol Chem; 1998 May; 273(18):10823-6. PubMed ID: 9556553
[TBL] [Abstract][Full Text] [Related]
46. WDR26 is a new partner of Axin1 in the canonical Wnt signaling pathway.
Goto T; Matsuzawa J; Iemura S; Natsume T; Shibuya H
FEBS Lett; 2016 May; 590(9):1291-303. PubMed ID: 27098453
[TBL] [Abstract][Full Text] [Related]
47. Phosphorylation and regulation of beta-catenin by casein kinase I epsilon.
Sakanaka C
J Biochem; 2002 Nov; 132(5):697-703. PubMed ID: 12417018
[TBL] [Abstract][Full Text] [Related]
48. Phosphorylation of axin within biomolecular condensates counteracts its tankyrase-mediated degradation.
Klement K; Brückner M; Bernkopf DB
J Cell Sci; 2023 Oct; 136(20):. PubMed ID: 37721093
[TBL] [Abstract][Full Text] [Related]
49. Axin PPI Networks: New Interacting Proteins and New Targets?
Song X; Cai W; Li L
Curr Top Med Chem; 2016; 16(30):3678-3690. PubMed ID: 27852210
[TBL] [Abstract][Full Text] [Related]
50. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin.
Ikeda S; Kishida S; Yamamoto H; Murai H; Koyama S; Kikuchi A
EMBO J; 1998 Mar; 17(5):1371-84. PubMed ID: 9482734
[TBL] [Abstract][Full Text] [Related]
51. Methylation by protein arginine methyltransferase 1 increases stability of Axin, a negative regulator of Wnt signaling.
Cha B; Kim W; Kim YK; Hwang BN; Park SY; Yoon JW; Park WS; Cho JW; Bedford MT; Jho EH
Oncogene; 2011 May; 30(20):2379-89. PubMed ID: 21242974
[TBL] [Abstract][Full Text] [Related]
52. A GSK3-binding peptide from FRAT1 selectively inhibits the GSK3-catalysed phosphorylation of axin and beta-catenin.
Thomas GM; Frame S; Goedert M; Nathke I; Polakis P; Cohen P
FEBS Lett; 1999 Sep; 458(2):247-51. PubMed ID: 10481074
[TBL] [Abstract][Full Text] [Related]
53. Axin forms a complex with MEKK1 and activates c-Jun NH(2)-terminal kinase/stress-activated protein kinase through domains distinct from Wnt signaling.
Zhang Y; Neo SY; Wang X; Han J; Lin SC
J Biol Chem; 1999 Dec; 274(49):35247-54. PubMed ID: 10575011
[TBL] [Abstract][Full Text] [Related]
54. An aggregon in conductin/axin2 regulates Wnt/β-catenin signaling and holds potential for cancer therapy.
Bernkopf DB; Brückner M; Hadjihannas MV; Behrens J
Nat Commun; 2019 Sep; 10(1):4251. PubMed ID: 31534175
[TBL] [Abstract][Full Text] [Related]
55. Insights into unbinding mechanisms upon two mutations investigated by molecular dynamics study of GSK3beta-axin complex: role of packing hydrophobic residues.
Zhang N; Jiang Y; Zou J; Zhuang S; Jin H; Yu Q
Proteins; 2007 Jun; 67(4):941-9. PubMed ID: 17380482
[TBL] [Abstract][Full Text] [Related]
56. A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation.
Zeng X; Tamai K; Doble B; Li S; Huang H; Habas R; Okamura H; Woodgett J; He X
Nature; 2005 Dec; 438(7069):873-7. PubMed ID: 16341017
[TBL] [Abstract][Full Text] [Related]
57. Differential molecular assemblies underlie the dual function of Axin in modulating the WNT and JNK pathways.
Zhang Y; Qiu WJ; Liu DX; Neo SY; He X; Lin SC
J Biol Chem; 2001 Aug; 276(34):32152-9. PubMed ID: 11408485
[TBL] [Abstract][Full Text] [Related]
58. Liquid-liquid phase separation drives the β-catenin destruction complex formation.
Shi Q; Kang K; Chen YG
Bioessays; 2021 Oct; 43(10):e2100138. PubMed ID: 34418117
[TBL] [Abstract][Full Text] [Related]
59. Threonine 393 of beta-catenin regulates interaction with Axin.
Wu H; Symes K; Seldin DC; Dominguez I
J Cell Biochem; 2009 Sep; 108(1):52-63. PubMed ID: 19565571
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice.
Xia YX; Lu L; Wu ZS; Pu LY; Sun BC; Wang XH
Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):278-84. PubMed ID: 22672822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
